Insider Transactions in Q2 2022 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
29,191
-2.22%
|
$379,483
$13.73 P/Share
|
Jun 16
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
20,809
-1.56%
|
$270,517
$13.58 P/Share
|
Jun 01
2022
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
1,000
-8.55%
|
$16,000
$16.67 P/Share
|
Jun 01
2022
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.87%
|
$7,000
$7.03 P/Share
|
May 26
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
19,687
-1.45%
|
$295,305
$15.77 P/Share
|
May 25
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
30,313
-2.19%
|
$454,695
$15.35 P/Share
|
May 18
2022
|
Mark Hair Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,200
+18.05%
|
$93,000
$15.8 P/Share
|
May 17
2022
|
John K Bakewell |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
May 17
2022
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
May 17
2022
|
Deepti Jain |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+44.86%
|
-
|
May 17
2022
|
Richard W Mott |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+0.14%
|
-
|
May 17
2022
|
Thomas E Timbie Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
May 17
2022
|
Betsy Hanna |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+44.86%
|
-
|
May 09
2022
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
120,000
-23.76%
|
-
|
May 09
2022
|
John R Treace Director |
SELL
Open market or private sale
|
Indirect |
75,000
-1.0%
|
$1,050,000
$14.67 P/Share
|
May 09
2022
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
1,000
-8.55%
|
$15,000
$15.96 P/Share
|
May 09
2022
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.87%
|
$7,000
$7.03 P/Share
|